PARLIAMENTARY WRITTEN QUESTION
Cystic Fibrosis (3 February 2017)
Question Asked
To ask the Secretary of State for Health, what assessment he has made of the potential merits of using cystic fibrosis treatments to pilot the recommendations of the Accelerated Access Review.
Asked by:
Kerry McCarthy (Labour)
Asked by:
Kerry McCarthy (Labour)
Answer
The Accelerated Access Review (AAR) published its recommendations last October and these are currently being considered by the Government.
The Review recommended the establishment of an Accelerated Access Partnership with the aim of getting strategically-important products to patients more quickly. If accepted, it will be for that body, which would include a wide range of representatives from industry and Government, to decide which treatments should be used to pilot the AAR’s recommendations.
The Government is considering the review’s recommendations and will provide a formal response in due course.
Answered by:
Baroness Blackwood of North Oxford (Conservative)
8 February 2017
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.